SIGA Technologies, Inc. (Nasdaq:SIGA), a company operating under the
protection of the United States Bankruptcy Court for the Southern
District of New York and specializing in the development and
commercialization of solutions for serious unmet medical needs and
biothreats, today announced that it has filed a notice of appeal from
the judgment of the Delaware Court of Chancery awarding PharmAthene,
Inc. expectation damages.
for SIGA Technologies, Inc. Appeals Judgment of Delaware Court of Chancery investment picks